Disrupting healthcare: Global CEOs shaping the future of health systems
The Global Health Exhibition 2025 (#GHE25) brought together some of the most influential leaders in healthcare, offering a rare glimpse into the strategies and innovations shaping the future of global health systems. A panel of top CEOs from industry giants like GSK, Sanofi, Royal Philips, BD, and MSD International reframed the concept of disruption, not as a series of technological upgrades, but as a fundamental rethinking of how healthcare systems operate, scale, and deliver value in an increasingly complex world.
This conversation was not about incremental change. It was about transformation. The panelists explored how structural forces, aging populations, the rise of chronic diseases, workforce shortages, financial pressures, and shifting patient expectations, are driving the need for bold, systemic innovation.
As Jonathan Symonds, Chairman of GSK, aptly put it, “We are seeing a completely different vision of healthcare. Not treating people when they’re sick, but preventing disease.” This shift from reactive to preventive care is not just a clinical strategy; it is the cornerstone of a sustainable healthcare future.
Disruption in healthcare is no longer defined by isolated technological breakthroughs. Instead, it emerges from the intersection of transformative trends that require a complete reimagining of the entire ecosystem.
- Aging populations and chronic disease: The global population is aging rapidly, and with it comes a surge in chronic conditions that strain healthcare systems. Symonds warned that without a decisive shift toward prevention, “the economic and social burden of an aging population is going to be enormous.”
- Geopolitical and regulatory complexity: Frédéric Oudéa, CEO of Sanofi, highlighted the dual challenge of navigating “incredible demographic trends” in a world that is becoming “more fragmented.” Geopolitical tensions, regulatory evolution, and disparities in access to care add layers of complexity to the healthcare landscape.
- Evolving patient expectations: Patients today demand more than treatment—they expect personalised, accessible, and continuous care. This shift in expectations is forcing healthcare providers to rethink how and where care is delivered.
- Technological acceleration: Advances in AI, data science, and digital technologies are reshaping the discovery, development, and delivery of therapies. Oudéa noted that these tools can “shorten development cycles and make research and development spending far more efficient,” turning efficiency into a form of disruption.
Roy Jakobs, CEO of Royal Philips, emphasised that the most significant disruptor in healthcare today is the widening gap between demand and system capacity. “The biggest disruptor in healthcare,” he explained, “is the growing gap between supply and demand.”
Traditional healthcare models are no longer sufficient to meet rising patient needs. Jakobs argued that the industry must move beyond product innovation to focus on productivity and measurable performance gains. “We need to move from products to productivity, making the healthcare sector far more efficient and patient-centric”
Artificial intelligence is central to this transformation. Jakobs highlighted how AI is already enabling data accuracy, speeding up interventions, and augmenting capacity in overwhelmed systems. This is not a futuristic vision, it is a present-day necessity.
One of the most profound shifts discussed at #GHE25 was the decentralisation of care. Tom Polen, CEO of BD, described how healthcare is entering a new era where patients can “recover faster than ever before.”
This acceleration is enabling a rethinking of care pathways, with diagnostics, monitoring, and even treatment increasingly moving into home and community settings. Decentralisation offers clear benefits: improved accessibility, reduced strain on healthcare systems, and greater convenience for patients.
However, Polen cautioned that this shift also introduces new challenges. “When care moves into the home, you have to consider the risk of family burnout,” he said, emphasising the need for technologies that prioritise usability and the human experience alongside clinical effectiveness.
Joseph Romanelli, President of MSD International, traced the evolution of healthcare innovation from small molecules to biologics, mRNA, and now gene and cell therapies. Each wave represents a more targeted and effective approach to treating disease.
Romanelli likened this progress to “building a better key to unlock the biology of disease,” with AI accelerating the design of these keys “faster and more precisely.”
Yet, he also highlighted a critical paradox: even as science advances, accessibility remains uneven. “We have interventions that can eliminate diseases like cervical cancer,” he noted, “but convincing the world to adopt them remains a challenge.”
This underscores a vital point: innovation must be paired with strategies to address affordability, trust, and equitable access. Without these, even the most groundbreaking therapies will fail to achieve their full potential.
Across every aspect of healthcare—diagnostics, therapeutics, AI, and decentralised care—one enabler consistently emerged: data.
Hudson described access to “well-structured data” as fundamental to future progress. Data powers AI, informs clinical decisions, accelerates R&D, enables precision medicine, and supports predictive and preventive care models.
Without it, disruption remains fragmented. With it, healthcare becomes more personalised, proactive, and scalable.
Despite the panel’s focus on AI, robotics, genomics, and advanced therapies, the closing reflections returned to a fundamental truth: disruption is ultimately about people.
As Symonds concluded, the next great transformation in healthcare will depend on “empowering patients who want to live healthier and longer lives.”
The future of healthcare will not be defined solely by what systems can deliver but by what individuals increasingly expect: preventive, personalised, accessible, and continuous care.
The #GHE25 CEO panel made it clear that the future of healthcare will be shaped by bold, systemic innovation. The path forward requires:
- Embedding prevention into the core of healthcare systems
- Driving productivity and efficiency to meet growing demand
- Leveraging AI and data responsibly to enhance capacity and outcomes
- Decentralising care to bring it closer to patients
- Ensuring equitable access to innovation
- Strengthening collaboration across the global healthcare ecosystem
Above all, the panel emphasised the need to maintain an unwavering focus on people. Because no matter how advanced healthcare becomes, its ultimate purpose remains the same: to extend and improve lives.
Join the movement driving the future of healthcare. Discover groundbreaking insights, connect with visionary leaders, and be part of the innovations transforming global health at #GHE26.
Secure your place today:
https://globalhealthexpo.info/li-social